Alpha Cognition Inc (ACOG) Stock Analysis
NASDAQHealthcareBiotechnology
What Alpha Cognition Inc does
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Key metrics
ETFs linked to ACOG
Broad-market and Healthcare sector ETFs an investor holding Alpha Cognition Inc is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ACOG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ACOG in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Alpha Cognition Inc?
- Alpha Cognition Inc trades under the ticker ACOG on NASDAQ.
- Which exchange is ACOG listed on?
- ACOG is listed on NASDAQ.
- What sector does Alpha Cognition Inc operate in?
- Alpha Cognition Inc is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze ACOG in a portfolio?
- PortView shows ACOG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.